Federal Circuit Affirms: Hospira Dexmedetomidine Patents Are Invalid

Mealey's (January 9, 2020, 3:24 PM EST) -- WASHINGTON, D.C. — A panel of the Federal Circuit U.S. Court of Appeals on Jan. 9 found no clear error in an Illinois federal judge’s holding that a single claim of a Hospira Inc. patent relating to dexmedetomidine would be obvious to a person of skill in the art (POSA) (Hospira Inc. v. Fresenius Kabi USA LLC, Nos. 2019-1329, -1367, Fed. Cir., 2020 U.S. App. LEXIS 545)....